<p>The vaccine industry has undergone a revolution in technology resulting in a variety of novel therapeutic platforms that accelerate development and significantly reduce the duration of process optimization and scale-up. However, challenges in maintaining efficacy and improving process robustness remain. In this presentation, we present a comparison of these novel technologies, discuss key considerations for manufacturing, and share selected case studies for platforms such as virus-like-particles, viral vectors, plasmid DNA, and mRNA platforms.</p>
<p><b>In this webinar, you will learn:</b></p>
<ul>
<li>Benefits of platform technologies in vaccine development</li>
<li>Key considerations when deciding between platforms</li>
<li>Vaccine pipeline analysis and selected case studies</li>
</ul>


aem-GridColumn aem-GridColumn--default--9

<br/><br/><h2 class="webinar-subtitle">WEBINAR</h2>

aem-GridColumn aem-GridColumn--default--9 aem-GridColumn--offset--default--0 aem-GridColumn--default--none

aem-GridColumn aem-GridColumn--default--3 aem-GridColumn--offset--default--0 aem-GridColumn--default--none

Compare novel technologies, manufacturing considerations, and case studies for virus-like-particles, viral vectors, plasmid DNA, and mRNA platforms in webinar.

Vaccine Development Platforms

WEBINAR